The global bioreactor market is projected to grow at a compound annual growth rate (CAGR) of around 7%, driven by the rising ...
HK Innoen announced on the 26th that it received the highest grade (AA) in the "2025 Second Half ESG Evaluation Results" ...
Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic ...
On November 20, 2025, at a closed-door, Q&A webinar on the proposed BIOSECURE Act, Joy Sturm, partner in the Hogan Lovells government ...
As the UAE celebrates its 54th Eid Al Etihad, I extend my warmest greetings to the leadership and the friendly people of this ...
6d
What enterprises should know about The White House's new AI 'Manhattan Project' the Genesis Mission
The White House fact sheet casts the initiative as a way to “transform how scientific research is conducted” and “accelerate ...
Mr. Farbstein will present the latest developments in Can-Fite’s advanced stage drug development pipeline including the ...
TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing ...
Q32 Bio Inc. ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, today announced ...
Donald Trump's 'Genesis Mission' is a massive national AI initiative launched by executive order, combining US experts, ...
Xeris Biopharma Holdings, Inc. , a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback